New combo therapy shows promise for Hard-to-Treat colorectal cancer

NCT ID NCT04963283

First seen Feb 11, 2026 · Last updated May 05, 2026 · Updated 12 times

Summary

This study tests whether combining two drugs, cabozantinib and nivolumab, can help control advanced colorectal cancer that has stopped responding to standard treatments. About 48 adults with a specific type of cancer (MSS) that has spread will receive the drug combination. The main goal is to see how many patients have their disease stabilized or reduced after 16 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • UCHealth Family Medicine - Greeley

    Greeley, Colorado, 80634, United States

  • UCHealth Harmony Campus

    Fort Collins, Colorado, 80528, United States

  • UCHealth Medical Center of the Rockies

    Loveland, Colorado, 80538, United States

  • UCHealth Memorial Hospital Central

    Colorado Springs, Colorado, 80909, United States

  • University of Colorado Hospital

    Aurora, Colorado, 80012, United States

Conditions

Explore the condition pages connected to this study.